Arkolith/Insider Trading/TXG/Form 4

Suliman Shehnaaz

Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$187K
Net Open-Market Flow
-$187K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Sell(S)5K$32.59$175K32K
Jun 16, 2026Sell(S)364$33.27$12K32K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000242) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML